INTRODUCTION
Neurofibromatosi (NF) is one of the most common genetic disorders associated with an incidence of 1 in 3500 live births. It is an autosomal dominant condition with a wide range of clinical manifestations. The aim of the study was to assess the maternal & perinatal outcome in pregnant patients with NF. Our cases add to the literature on aggravation of neurofibromatosis in pregnancy and higher chance of complications in pregnancy with NF.
CASE REPORT
Two cases of pregnancy with NF were reported in a span of 1 year from Aug 2013 to July 2014 among 12439 deliveries.
First case was a 25 year old woman who was referred to emergency as a case of NF with APH and PIH. She was G3P2L2A0.
On examination general condition was average; she was afebrile with pallor & icterus present. There were multiple big &small fibromas all over the body. On account of bleeding placenta praevia pregnancy was terminated by caesarian section and a preterm neonate of 2 kg with APGAR score 6/7 at 1 /5min was born which was immediately admitted in NICU. On discharge the patient was referred to gastroenterologist for obstructive jaundice for ERCP. On examination general condition was average. She had numerous large and small neurofibromas all over the body with a big plexiform mass hanging out from right eye. Her BP was 120/80 mmHg, pulse 88/min. On per abdomen uterus term size, FHS +R, cephalic, uterus mildly acting. On per vaginum os one finger, started taken up, membranes +, vertex at -3 stn.
Dinoprostone gel was introduced for augmentation of labour. After 48 hours also there was no progress so caesarean was decided with failed induction and postdatism .A healthy female child was born.
On fourth postop day she developed fits which were GTCS in nature. She was normotensive and urine albumin was nil. Neurophysician reference was done who advised loading dose of phenytoin followed by maintenance dose and CT scan head was done which showed a space occupying lesion meningioma. She was discharged on tab phenytoin and referred to neurosurgeon after which she lost follow up. NF-I (von Recklinghausen's disease) is an autosomal dominant disorder with incidence of 1 in 3500, approximately half cases are familial, remainder are new mutations arising in patients with unaffected parents. NF-I gene is present on chromosome 17q codes for a huge protein neurofibromin, a GTPase activating protein (GAP) that modulates signalling through Ras pathway. Mutations in NF-I gene result in a large number of nervous system tumors including neurofibromas, plexiform neurofibroma, optic nerve gliomas, strocytomas, meningiomas. In addition to neurofibromas which appear as multiple, soft rubbery cutaneous tumors, other cutaneous manifestations include café-au-lait spots and axillary freckling. NF-I is also associated with hamartomas of the iris -LISCH nodules, pheochromocytomas, pseudoarthrosis of tibia, scoliosis, epilepsy and mental retardation. NF-II is less common than NF-I with an incidence of 25000-40000. It is also an autosomal dominant condition. NF-II gene present on chromosome 22q encodes a cytoskeletal protein MERLIN that functions as a tumor
